Clinical Trials in Phoenix

Showing 6321-6340 of 16,646 trials

DeepView SnapShot Portable (DV-SSP): Device Training Study

NCT05023135

The purpose of this study is to continue development and validation of an algorithm for burn healing assessment by the Spectral MD DeepView device and provide burn healing potential assessment.

BurnsWound Heal

SpectralMD251 participantsStarted Sep 2021

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Bridgeport, Connecticut, United States +8 more locations

COMPLETED< 1 mile

A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)

NCT02294877

The objectives of this program are: to characterize and describe the Mucopolysaccharidosis IV type A (MPS IVA) population as a whole, including the heterogeneity, progression, and natural history of MPS IVA; to evaluate the long-term effectiveness and safety of Vimizim®, including, but not limited to, the occurrence of serious hypersensitivity reactions, anaphylaxis, and changes in antibody status; to help the medical community with the development of recommendations for monitoring MPS IVA patients and reports on patient outcomes to optimize patient care; to collect data on other treatment paradigms, and evaluate the prevalences of their use and their effectiveness; to characterize the effects and safety of Vimizim treatment 5 years from enrollment in the Registry for patients under 5 years of age; to monitor pregnancy exposure, including maternal, neonatal, and infant outcomes; and to monitor patients who have completed the MOR-005 and MOR-007 clinical trials. These patients will be encouraged to enroll in the applicable Registry Substudy and will be monitored using the MOR-005 and MOR-007 assessment schedules, respectively.

Mucopolysaccharidosis IV Type AMorquio A SyndromeMPS IVA

BioMarin Pharmaceutical418 participantsStarted Sep 2014

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +76 more locations

DeepView SnapShot Portable (DV-SSP): Device Training Study

A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)

Find Trials by Condition in Phoenix

Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study

Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis

DCBY02 as a Monotherapy in Patients With Advanced or Metastatic Solid Tumors

Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)

A Clinical Utility Study of PrismRA for Rheumatoid Arthritis

On-X Heart Valve - 17mm Aortic and 23mm Mitral

Randomized Clinical Study Comparing SynPath to Standard of Care in Treatment of Chronic Diabetic Foot Ulcers

Strategic Timing of Antiretroviral Treatment

A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life

LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma

AuriNovo for Auricular Reconstruction

Sorin Universal REgistry on Aortic Valve Replacement

Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement

CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection

BMS-986012 in Relapsed/Refractory SCLC